Trinity Biotech (TRIB) Net Income towards Common Stockholders (QoQ) (2009 - 2024)
Trinity Biotech (TRIB) Net Income towards Common Stockholders (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.50 Mn | 1.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -256.27% |
| Sep 30, 2024 | 29.57% |
| Jun 30, 2024 | -103.71% |
| Mar 31, 2024 | 39.71% |
| Dec 31, 2023 | 18.14% |
| Sep 30, 2023 | -12.24% |
| Jun 30, 2023 | -3.08% |
| Mar 31, 2023 | 42.37% |
| Dec 31, 2022 | -12.69% |
| Sep 30, 2022 | 7.84% |
| Jun 30, 2022 | 20.95% |
| Mar 31, 2022 | -871.44% |
| Dec 31, 2021 | -195.69% |
| Sep 30, 2021 | 268.71% |
| Jun 30, 2021 | -148.88% |
| Mar 31, 2021 | 115.98% |
| Dec 31, 2020 | -236.85% |
| Sep 30, 2020 | 599.32% |
| Jun 30, 2020 | 33.98% |
| Mar 31, 2020 | -255,402,198.85% |